Targeted Therapies Extend Lives as More Americans Live With Cancer
An expanding suite of targeted cancer treatments, along with immunotherapies, hormone pills and chemotherapy, is contributing to a rising number of Americans living with cancer. Improved understanding of cancer biology, patient selection by genetic markers and clinical trial advances have raised five-year survival rates and produced new life-extend…